Prostate cancer testing can feel overwhelming, but Alan’s journey shows it doesn’t have to be. EpiSwitch® PSE helped him avoid an unnecessary biopsy when he didn’t need one—and take action when he did. A simple blood test gave him and his doctor clear answers at every step. 📌

🧬 Good to see Oxford BioDynamics’ EpiSwitch #PSE test featured again in The The Telegraph today, highlighting the role that the blood test's accuracy is playing in detecting #ProstateCancer. Read the full article here: telegraph.co.uk/health-fitness… #OBD #MensHealth 94percent.com

Together, we can drive change. Prostate cancer screening reform could transform health outcomes for thousands of men while delivering economic benefit to the country too. Join our campaign network and be part of the change: mailchi.mp/pcr.org.uk/pro…

I got prostate cancer at 47 despite having no symptoms — why my doctor sent me for a screening trib.al/lIGKvGu

3. The sneaky threat: Prostate cancer #2 on the men’s cancer chart. But early snitches get stitches. Screening = survival. Your game plan: • PSA blood poke • The not-so-fun finger test (DRE) • Start yearly checks at 40 (sooner if it runs in the fam)

#OBD Oxford BioDynamics’ #EpiSwitchPSE test for #ProstateCancer is now offered at The London GP TLGP—Harley Street’s private GP serving 10,000 patients. We continue to grow our provider network. 🔗Visit mypse.co/tlgp. HCA Healthcare HCA Healthcare UK 94percent.com

📣 I am looking forward to sitting down with the Urology News editor at the #BAUS25 Annual Scientific Meeting in #Manchester (16 June) to update readers on #OBD progress with the #EpiSwitchPSE #ProstateCancer blood test. Please message me to meet at BAUS. BAUS Oxford BioDynamics

The The Telegraph highlights #EpiSwitchPSE as a next-gen test reducing false positives in #ProstateCancer testing. Better testing ➡️ earlier diagnosis ➡️ better outcomes. 📖 Read more: mypse.co/ld8. #EarlyDetectionSavesLives

This May, we’re proud to recognize the scientists, clinicians, and patients who drive progress in cancer research. At OBD, innovation is at the heart of our mission to advance personalized healthcare for life-changing diseases like cancer. #NationalCancerResearchMonth #NCRM25

#OBD Oxford BioDynamics Interview with Senior Commercial Director ‘This company has unlocked 3G Genomics in a way that multi-billion dollar pharma in the US have just not managed to do’ #episwitch #prostatecancer #biotech #pharma youtu.be/EGh1-fEaiso?si…

We appreciate your support in helping make precision #diagnostics more accessible. It’s exciting to see the #OBD #EpiSwitchPSE test making a real impact in clinics across the UK — a big step forward for early #ProstateCancer detection. 94percent.com

🩺 June is #MensHealthMonth—there’s no better time to talk #Cancer #EarlyDetection. Join Oxford BioDynamics (#OBD) as we kick off the month with advocate alfredsamuels, who shares his deeply personal #ProstateCancer story. Learn how the #EpiSwitchPSE test can help you 94percent.com

Prostate cancer is the most diagnosed cancer in UK men. Yet many still go undetected until it’s advanced and treatment is 'far less certain to succeed.' mypse.co/b4b In The Telegraph , Rishi Sunak calls for national screening. We support this push for earlier, accurate

✔️Day 1 of #BAUS25 complete. Thank you #UrologyNews team for sharing this about Oxford BioDynamics' (#OBD) #EpiSwitchPSE #prostatecancer detection blood test today at the BAUS annual meeting. Urology News TheUrologyFoundation

🏃‍♀️Thanks to all the volunteers behind the #BAUS25 fun run supporting The Urology Foundation #TUF. This year Bartu Ahiska represented our #OBD team behind the #EpiSwitchPSE #ProstateCancer blood test. Already looking forward to 2026! BAUS BSoT #BSoTFunRun #urology

Major win: our paper on #EpiSwitchPSE just earned a 2023 Best Paper Award from Cancers MDPI. This is a huge step forward for blood-based prostate cancer diagnostics. Congrats to the entire team. Read it here: obdx.co/ol2. #CancerResearch #OBD #3Dgenomics

🎙️Insightful #ProstateCancer testing primer—including a discussion of Oxford BioDynamics' #EpiSwitchPSE at ~12min—from Tim Woodman, Bupa Medical Director, and Richard, reflecting on his cancer. The #OBD #PSE blood test (94percent.com) is available under Bupa youtube.com/watch?si=w-e_w…

📰“A British-made #ProstateCancer test could remove the need for biopsies in 4 out of 5 cases” —Daily Mail covers an Oxford BioDynamics study showing compelling evidence from a US #urology clinic on #EpiSwitchPSE’s real-world impact. obdx.co/dm2 MDPI #OBD

The genome folds and interacts in 3D. Our new perspective article in Cancers MDPI, with University of Oxford, shows how the EpiSwitch® platform uses this to enable biomarkers for accurate diagnosis, prognosis & therapy response from a simple blood test: obdx.co/23z.

How is #3DGenomics reshaping molecular research? Join #OBD CSO Alexandre Akoulitchev & Agilent Technologies's Valentina Maran to explore the EpiSwitch® Explorer Array Kit—interrogating nearly 1M high-confidence conformations. Register: obdx.co/qpm. #PrecisionMedicine GenomeWeb